MihailObroceaMD

Oncology • Valencia, CA

Oncologist in Valencia, California

Join to view full profile

Dr. Obrocea is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Obrocea's full profile

Already have an account?

Office
28903 Avenue Paine
Valencia, CA 91355
Phone+1 661-775-5365

Fax+1 661-775-2080

Education & Training

Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 1996 - 1999
Norwalk Hospital/Yale UniversityResidency, Internal Medicine, 1993 - 1996
University of OttawaMS, Biochemistry, 1990 - 1992
Carol Davila University of Medicine and PharmacyClass of 1985

Certifications & Licensure

CA State Medical License 2009 - 2025
MD State Medical License 2005 - 2025
NH State Medical License 1997 - 2025

Clinical Trials

Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC) Start of enrollment: 2005 Jan 01
Terminated
Phase 2
A Study of Volociximab in Metastatic Melanoma Start of enrollment: 2006 Dec 01
Terminated
Phase 2
A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer Start of enrollment: 2005 Mar 01
Completed
Phase 2
Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin) Start of enrollment: 2007 Jul 01
Completed
Phase 1, Phase 2
A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2007 Dec 01
Completed
Phase 1
A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC) Start of enrollment: 2008 Apr 01
Completed
Phase 1
A Trial of PDL192 in Subjects With Advanced Solid Tumors Start of enrollment: 2008 Jul 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

59 citations
A Phase 1 Study of a Vaccine Targeting Preferentially Expressed Antigen in Melanoma and Prostate-specific Membrane Antigen in Patients With Advanced Solid Tumors
Jeffrey S. Weber, Nicholas J. Vogelzang, Marc S. Ernstoff, Oscar B. Goodman, Lee D. Cranmer
Journal of Immunotherapy. 2011-09-01
50 citations
Intra–Lymph Node Prime-Boost Vaccination against Melan A and Tyrosinase for the Treatment of Metastatic Melanoma: Results of a Phase 1 Clinical Trial
Antoni Ribas, Jeffrey S. Weber, Bartosz Chmielowski, Begonya Comin-Anduix, David S.K. Lu
Clinical Cancer Research. 2011-05-01
1 citations
Cancer vaccines at an inflexion point: what next?
Adrian Bot, Mihail Obrocea, Francesco M. Marincola
Journal of Translational Medicine. 2011-09-09

Authored Content

Cancer Vaccines From Research To Clinical PracticeJune 2011
Cancer Vaccines Challenges and Opportunities in TranslationMarch 2008